AcuraStem

AcuraStem is a patient-based biotechnology company that is revolutionizing the way treatments are developed for neurodegenerative diseases.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

Search Tags

biotechnology, neurodegenerative diseases, patient-based therapeutics

About Us

AcuraStem is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, including ALS and frontotemporal dementia. Utilizing its proprietary iNeuroRx® platform, AcuraStem creates patient-derived disease models that accurately reflect the complexities of these conditions. By integrating advanced AI techniques, the company aims to identify effective therapeutics tailored to individual patient needs, enhancing the potential for successful treatment outcomes in neurodegeneration.

Trending Companies in AI

Latest Articles in AI

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >
Anycubic Photon Mono M7 Pro for $469 with code AC30OFF. FREE $99 Gifts: 1*High Speed Resin+2*FEP Film+3000pcs Limited Mystery Box

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies